Proteomic analysis of lung tissue in a rat acute lung injury model: Identification of PRDX1 as a promoter of inflammation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Liu, Dongdong ^a   Mao, Pu ^a   Huang, Yongbo ^a   Liu, Yiting ^a   Liu, Xiaoqing ^a   Pang, Xiaoqing ^a   Li, Yimin ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN E; BINDING PROTEIN; CALRETICULIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTATHIONE TRANSFERASE ALPHA; GLUTATHIONE TRANSFERASE ALPHA 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HAPTOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN GALACTOSE BINDING SOLUBLE 5 PROTEIN; LIPOPOLYSACCHARIDE; MALATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; NUCLEOSIDE DIPHOSPHATE KINASE B; NUCLEOSIDE DIPHOSPHATE KINASE D; PEROXIREDOXIN 1; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; PREALBUMIN; PROTEIN KINASE; RHO ASSOCIATED KINASE 1; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; SHORT HAIRPIN RNA; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; PEROXIREDOXIN; PRDX1 PROTEIN, RAT;

ACUTE LUNG INJURY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DOWN REGULATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IN VITRO STUDY; INFLAMMATION; LUNG PARENCHYMA; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; RAT; RAT MODEL; RESPIRATORY EPITHELIUM; UPREGULATION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; CELL LINE; CHEMICALLY INDUCED; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT; TOXICITY;

ACUTE LUNG INJURY; ANIMALS; CELL LINE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LUNG; MALE; PEROXIREDOXINS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904135583     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/469358     Document Type: Article

References (45)

1. Rubenfeld G. D., Caldwell E., Peabody E., Weaver J., Martin D. P., Neff M., Stern E. J., Hudson L. D., Incidence and outcomes of acute lung injury. The New England Journal of Medicine 2005 353 16 1685 1693 2-s2.0-26844552488 10.1056/NEJMoa050333 (Pubitemid 41464707)
2. Matthay M. A., Ware L. B., Zimmerman G. A., The acute respiratory distress syndrome. Journal of Clinical Investigation 2012 122 8 2731 2740 2-s2.0-84864742993 10.1172/JCI60331
3. Liaudet L., Mabley J. G., Pacher P., Virág L., Soriano F. G., Marton A., Haskó G., Deitch E. A., Szabó C., Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Annals of Surgery 2002 235 4 568 578 2-s2.0-0036203190 10.1097/00000658- 200204000-00016 (Pubitemid 34258357)
4. Gao L., Barnes K. C., Recent advances in genetic predisposition to clinical acute lung injury. American Journal of Physiology: Lung Cellular and Molecular Physiology 2009 296 5 L713 L725 2-s2.0-66149183017 10.1152/ajplung.90269.2008
5. Curley G., Hayes M., Laffey J. G., Can "permissive" hypercapnia modulate the severity of sepsis-induced ALI/ARDS? Critical Care 2011 15 2, article 212 2-s2.0-79953017464 10.1186/cc9994
6. Opitz B., van Laak V., Eitel J., Suttorp N., Innate immune recognition in infectious and noninfectious diseases of the lung. American Journal of Respiratory and Critical Care Medicine 2010 181 12 1294 1309 2-s2.0-77954468897 10.1164/rccm.200909-1427SO
7. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M. A., Fukamizu A., Hui C.-C., Hein L., Uhlig S., Slutsky A. S., Jiang C., Penninger J. M., Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005 436 7047 112 116 2-s2.0-21844460785 10.1038/nature03712 (Pubitemid 40966195)
8. Kuba K., Imai Y., Penninger J. M., Angiotensin-converting enzyme 2 in lung diseases. Current Opinion in Pharmacology 2006 6 3 271 276 2-s2.0-33646352935 10.1016/j.coph.2006.03.001 (Pubitemid 43670913)
9. Serhan C. N., Brain S. D., Buckley C. D., Gilroy D. W., Haslett C., O'Neill L. A. J., Perretti M., Rossi A. G., Wallace J. L., Resolution of inflammation: state of the art, definitions and terms. FASEB Journal 2007 21 2 325 332 2-s2.0-33846823024 10.1096/fj.06-7227rev (Pubitemid 46213480)
10. Righetti P. G., Castagna A., Hamdan M., Recent trends in proteome analysis. Advances in Chromatography 2003 42 269 321 2-s2.0-0037268571
11. Liu K.-X., Li C., Li Y.-S., Yuan B.-L., Xu M., Xia Z., Huang W.-Q., Proteomic analysis of intestinal ischemia/reperfusion injury and ischemic preconditioning in rats reveals the protective role of aldose reductase. Proteomics 2010 10 24 4463 4475 2-s2.0-78650050186 10.1002/pmic.201000078
12. Janz D. R., Ware L. B., Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials. Seminars in Respiratory and Critical Care Medicine 2013 34 4 537 548 2-s2.0-84881581885 10.1055/s-0033-1351124
13. Ménoret A., Kumar S., Vella A. T., Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS ONE 2012 7 7 2-s2.0-84863698432 10.1371/journal.pone.0040184 e40184
14. Schnapp L. M., Donohoe S., Chen J., Sunde D. A., Kelly P. M., Ruzinski J., Martin T., Goodlett D. R., Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. American Journal of Pathology 2006 169 1 86 95 2-s2.0-33745686482 10.2353/ajpath.2006.050612
15. Chang D. W., Hayashi S., Gharib S. A., Vaisar T., King S. T., Tsuchiya M., Ruzinski J. T., Park D. R., Matute-Bello G., Wurfel M. M., Bumgarner R., Heinecke J. W., Martin T. R., Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2008 178 7 701 709 2-s2.0-52749097637 10.1164/rccm.200712-1895OC
16. Cabrera-Benitez N. E., Pérez-Roth E., Casula M., Ramos-Nuez Á., Ríos-Luci C., Rodríguez-Gallego C., Sologuren I., Jakubkiene V., Slutsky A. S., Padrón J. M., Villar J., Anti-inflammatory activity of a novel family of aryl ureas compounds in an endotoxin-induced airway epithelial cell injury model. PLoS ONE 2012 7 11 2-s2.0-84869020324 10.1371/journal.pone.0048468 e48468
17. Cripps A. W., Dunkley M. L., Clancy R. L., Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infection and Immunity 1994 62 4 1427 1436 2-s2.0-0028208496 (Pubitemid 24110839)
18. Vanderzwan J., McCaig L., Mehta S., Joseph M., Whitsett J., McCormack D. G., Lewis J. F., Characterizing alterations in the pulmonary surfactant system in a rat model of Pseudomonas aeruginosa pneumonia. The European Respiratory Journal 1998 12 6 1388 1396 2-s2.0-0032421057 10.1183/09031936.98.12061388 (Pubitemid 29011435)
19. Nishina K., Mikawa K., Takao Y., Maekawa N., Shiga M., Obara H., ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesthesia and Analgesia 1997 84 5 1097 1103 2-s2.0-0030966832 (Pubitemid 27197673)
20. Eckle T., Füllbier L., Wehrmann M., Khoury J., Mittelbronn M., Ibla J., Rosenberger P., Eltzschig H. K., Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. Journal of Immunology 2007 178 12 8127 8137 2-s2.0-34250155915 (Pubitemid 46898085)
21. Li J., Zhang N., Song L.-B., Liao W.-T., Jiang L.-L., Gong L.-Y., Wu J., Yuan J., Zhang H.-Z., Zeng M.-S., Li M., Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clinical Cancer Research 2008 14 11 3319 3326 2-s2.0-50349090038 10.1158/1078-0432.CCR-07-4054
22. Park E.-J., Yi J., Chung K.-H., Ryu D.-Y., Choi J., Park K., Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicology Letters 2008 180 3 222 229 2-s2.0-49749131612 10.1016/j.toxlet.2008.06.869
23. Riddell J. R., Bshara W., Moser M. T., Spernyak J. A., Foster B. A., Gollnick S. O., Peroxiredoxin 1 controls prostate cancer growth through toll-like receptor 4-dependent regulation of tumor vasculature. Cancer Research 2011 71 5 1637 1646 2-s2.0-79952231198 10.1158/0008-5472.CAN-10-3674
24. Chang J. W., Lee S. H., Lu Y., Yoo Y. J., Transforming growth factor- β 1 induces the non-classical secretion of peroxiredoxin-I in A549 cells. Biochemical and Biophysical Research Communications 2006 345 1 118 123 2-s2.0-33646417688 10.1016/j.bbrc.2006.04.073
25. Liu Y., Mao P., Liu X. Q., He W. Q., Mo H. Y., Li Y. M., Lipopolysaccharide induced expression of peroxiredoxin 1 in airway epithelial cell. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2013 25 3 136 139
26. Riddell J. R., Wang X.-Y., Minderman H., Gollnick S. O., Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. Journal of Immunology 2010 184 2 1022 1030 2-s2.0-76249112140 10.4049/jimmunol.0901945
27. Bellani G., Messa C., Guerra L., Spagnolli E., Foti G., Patroniti N., Fumagalli R., Musch G., Fazio F., Pesenti A., Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT study. Critical Care Medicine 2009 37 7 2216 2222 2-s2.0-67649766888 10.1097/CCM.0b013e3181aab31f
28. Bellani G., Guerra L., Musch G., Zanella A., Patroniti N., Mauri T., Messa C., Pesenti A., Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury. American Journal of Respiratory and Critical Care Medicine 2011 183 9 1193 1199 2-s2.0-79955490275 10.1164/rccm.201008-1318OC
29. Sun H., Breslin J. W., Zhu J., Yuan S. Y., Wu M. H., Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006 13 3 237 247 2-s2.0-33645116978 10.1080/10739680600556944
30. Mckenzie J. A. G., Ridley A. J., Roles of Rho/ROCK and MLCK in TNF- α -induced changes in endothelial morphology and permeability. Journal of Cellular Physiology 2007 213 1 221 228 2-s2.0-34548478100 10.1002/jcp.21114 (Pubitemid 47378810)
31. Jia L., Xu M., Zhen W., Shen X., Zhu Y., Wang W., Wang X., Novel anti-oxidative role of calreticulin in protecting A549 human type II alveolar epithelial cells against hypoxic injury. American Journal of Physiology: Cell Physiology 2008 294 1 C47 C55 2-s2.0-38349139745 10.1152/ajpcell.00019.2007
32. Li C., Jackson R. M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury. American Journal of Physiology: Cell Physiology 2002 282 2 C227 C241 2-s2.0-0036080614 (Pubitemid 34663181)
33. Liu H., Peatman E., Wang W., Abernathy J., Liu S., Kucuktas H., Lu J., Xu D.-H., Klesius P., Waldbieser G., Liu Z., Molecular responses of calreticulin genes to iron overload and bacterial challenge in channel catfish (Ictalurus punctatus). Developmental and Comparative Immunology 2011 35 3 267 272 2-s2.0-79151470511 10.1016/j.dci.2010.11.009
34. Ghio A. J., Carter J. D., Richards J. H., Richer L. D., Grissom C. K., Elstad M. R., Iron and iron-related proteins in the lower respiratory tract of patients with acute respiratory distress syndrome. Critical Care Medicine 2003 31 2 395 400 2-s2.0-0037323975 10.1097/01.CCM.0000050284.35609.97 (Pubitemid 36232931)
35. Chen M.-F., Keng P. C., Shau H., Wu C.-T., Hu Y.-C., Liao S.-K., Chen W.-C., Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. International Journal of Radiation Oncology Biology Physics 2006 64 2 581 591 2-s2.0-30544431972 10.1016/j.ijrobp.2005.10.012 (Pubitemid 43083448)
36. Riddell J. R., Maier P., Sass S. N., Moser M. T., Foster B. A., Gollnick S. O., Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1 α PLoS ONE 2012 7 11 2-s2.0-84869851093 10.1371/journal.pone.0050394 e50394
37. Shichita T., Hasegawa E., Kimura A., Morita R., Sakaguchi R., Takada I., Sekiya T., Ooboshi H., Kitazono T., Yanagawa T., Ishii T., Takahashi H., Mori S., Nishibori M., Kuroda K., Akira S., Miyake K., Yoshimura A., Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nature Medicine 2012 18 6 911 917 2-s2.0-84861999263 10.1038/nm.2749
38. Gharib S. A., Nguyen E., Altemeier W. A., Shaffer S. A., Doneanu C. E., Goodlett D. R., Schnapp L. M., Of mice and men: comparative proteomics of bronchoalveolar fluid. The European Respiratory Journal 2010 35 6 1388 1395 2-s2.0-77953523394 10.1183/09031936.00089409
39. Kim S.-U., Park Y.-H., Min J.-S., Sun H.-N., Han Y.-H., Hua J.-M., Lee T.-H., Lee S.-R., Chang K.-T., Kang S. W., Kim J.-M., Yu D.-Y., Lee S.-H., Lee D.-S., Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF- B-mediated iNOS induction and microglial activation. Journal of Neuroimmunology 2013 259 1-2 26 36 2-s2.0-84877596486 10.1016/j.jneuroim.2013. 03.006
40. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G., Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generatedin response to growth factors and tumor necrosis factor- α The Journal of Biological Chemistry 1998 273 11 6297 6302 2-s2.0-0141746553 10.1074/jbc.273.11.6297 (Pubitemid 28144719)
41. Ishii T., Warabi E., Yanagawa T., Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. Journal of Clinical Biochemistry and Nutrition 2012 50 2 91 105 2-s2.0-84857835586 10.3164/jcbn.11-109
42. Kang S. W., Rhee S. G., Chang T.-S., Jeong W., Choi M. H., 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends in Molecular Medicine 2005 11 12 571 578 2-s2.0-28244495868 10.1016/j.molmed.2005.10.006 (Pubitemid 41713999)
43. Sue G. R., Ho Z. C., Kim K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radical Biology and Medicine 2005 38 12 1543 1552 2-s2.0-19444375216 10.1016/j.freeradbiomed.2005.02.026 (Pubitemid 40726061)
44. Wood Z. A., Schröder E., Harris J. R., Poole L. B., Structure, mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences 2003 28 1 32 40 2-s2.0-0037222255 10.1016/S0968-0004(02)00003-8 (Pubitemid 36051004)
45. Yanagisawa R., Warabi E., Inoue K.-I., Yanagawa T., Koike E., Ichinose T., Takano H., Ishii T., Peroxiredoxin I null mice exhibits reduced acute lung inflammation following ozone exposure. Journal of Biochemistry 2012 152 6 595 601 2-s2.0-84870865760 10.1093/jb/mvs113